查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529847

分子影像市場規模、佔有率、趨勢分析報告：按模式、應用、最終用途、地區和細分市場預測，2024-2030 年

Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 220 Pages | 商品交期: 2-10個工作天內

價格

分子影像市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球分子影像市場規模將達到114.4億美元，2024年至2030年複合年成長率為4.52%。

市場成長的主要因素包括技術進步、癌症盛行率的增加以及研發投資的增加。例如，根據國際癌症研究機構的數據，2022 年全球將報告約 19,976,499 例新癌症病例和 9,743,832 例癌症相關死亡。

癌症、心血管疾病和神經系統疾病等慢性疾病的盛行率不斷上升，需要有效的診斷工具，預計將顯著促進分子影像市場的成長。 PET（正子斷層掃描）、SPECT（單光子發射電腦斷層掃描）和 NMR（核磁共振）光譜儀等分子影像儀器在這方面特別有效。這些先進技術提供了對與各種疾病相關的代謝過程、分子活動和結構變化的詳細了解。這些使醫療保健專業人員能夠高精度地可視化和評估腫瘤的範圍和特徵、心臟功能和神經系統異常。

此外，分子影像有助於疾病的早期發現，甚至在亞臨床階段，從而可以及時干預和個人化治療計劃。這種積極主動的方法不僅可以改善患者的治療效果，還可以降低與晚期疾病階段和併發症相關的醫療費用。

主要市場參與者採取的策略性舉措，如併購、產品發布、監管核准、聯盟、合作以及研發 (R&D) 活動在推動分子影像市場的成長中發揮關鍵作用。例如，2024 年 1 月，布魯克公司在俄亥俄州立大學國家門戶超高場核磁共振中心成功安裝了最先進的 1.2吉赫(GHz) 核磁共振系統。這種 GHz 級 NMR 系統代表了核磁共振 (NMR) 波譜學的重大進步，旨在徹底改變生命科學和材料科學研究。

分子成像市場報告亮點

  • 按模式分類，單光子放射電腦斷層掃描 (SPECT) 領域將在 2023 年佔據主導地位，佔有率為 43.8%。
  • 核磁共振 (NMR) 波譜儀領域預計從 2024 年到 2030 年將以最快的複合年成長率成長。
  • 按應用分類，腫瘤學領域佔據最大的市場佔有率，2023 年佔有率為 33.7%。
  • 按最終用途分類，到 2023 年，醫院領域將佔據市場的大部分佔有率。
  • 診斷成像中心領域預計將從 2024 年到 2030 年以最快的速度成長。
  • 2023年北美佔41.7%的佔有率。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章分子影像市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 分子影像市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章分子影像市場：依模態估計與趨勢分析

  • 細分儀表板
  • 依方式分析全球分子影像市場變化
  • 2018-2030 年全球分子影像市場規模與趨勢分析（按模式）
  • 分子超音波成像
  • 正子斷層掃描 (PET)
  • 單光子發射電腦斷層掃描 (SPECT)
  • 核磁共振 (NMR) 波譜儀
  • 其他方式

第5章分子影像市場：按應用估計和趨勢分析

  • 細分儀表板
  • 全球分子影像市場按應用變化分析
  • 2018-2030年全球分子影像市場規模及趨勢分析（依應用）
  • 心血管
  • 神經病學
  • 腫瘤學
  • 呼吸系統
  • 胃腸道

第6章分子影像市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 按最終用途分類的全球分子成像市場變化分析
  • 2018-2030 年全球分子影像市場規模與趨勢分析（依最終用途）
  • 醫院
  • 影像診斷中心
  • 調查機構

第7章分子影像市場：按應用和最終用途的區域估計和趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 2023年主要企業市場佔有率分析
  • 公司定位分析
  • 公司分類（新興企業、創新企業、領導者）
  • 公司簡介
    • Bruker
    • GE HealthCare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Mediso, Cubresa Inc.
    • Shimadzu Corporation
    • United Imaging Healthcare Co
    • Positron Corporation
Product Code: GVR-4-68040-374-6

Molecular Imaging Market Growth & Trends:

The global molecular imaging market size is anticipated to reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
  • The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated to grow at the fastest CAGR from 2024 to 2030
  • Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
  • Based on end use, the hospital segment held a majority share of the market in 2023.
  • Diagnostic imaging centers segment is expected to grow at the fastest rate from 2024 to 2030
  • North America dominated the market with a share of 41.7% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer and other chronic diseases
      • 3.2.1.2. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Equipment and Treatment
  • 3.3. Molecular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Molecular Imaging Modality Market Movement Analysis
  • 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Molecular Ultrasound Imaging
    • 4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Positron Emission Tomography (PET)
    • 4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Single Photon Emission Computed Tomography (SPECT)
    • 4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
    • 4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Other Modalities
    • 4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Molecular Imaging Application Market Movement Analysis
  • 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Respiratory
    • 5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Gastrointestinal
    • 5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Molecular Imaging End Use Market Movement Analysis
  • 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Research institutes
    • 6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis By Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. Bruker
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. GE HealthCare
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Koninklijke Philips N.V.
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Canon Medical Systems Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso, Cubresa Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Shimadzu Corporation
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare Co
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Positron Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Molecular Imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Molecular imaging market driver impact
  • Fig. 19 Molecular imaging market restraint impact
  • Fig. 20 Molecular imaging market: Modality movement analysis
  • Fig. 21 Molecular imaging market: Modality outlook and key takeaways
  • Fig. 22 Molecular ultrasound imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Positron emission tomography (PET) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Single photon emission computed tomography (SPECT) market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 25 Nuclear magnetic resonance (NMR) spectrometer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other modalities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular imaging market: Application movement analysis
  • Fig. 28 Molecular imaging market: Application outlook and key takeaways
  • Fig. 29 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Molecular imaging market: End use movement analysis
  • Fig. 35 Molecular imaging market: End use outlook and key takeaways
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic imaging centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Global molecular imaging market: Regional movement analysis
  • Fig. 40 Global molecular imaging market: Regional outlook and key takeaways
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy
  • Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden
  • Fig. 64 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Norway
  • Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico
  • Fig. 86 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait
  • Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Market share of key market players- Molecular imaging market